Materiality pending
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
- Haemonetics acquires Attune Medical for $160 million, boosting the global Hospital business. - Attune Medical generated $22 million in revenue in fiscal 2023, expected accretive to Haemonetics. - Attune's ensoETM technology enhances Haemonetics' presence in electrophysiology market. - Transaction financed through cash and credit facility draw, expected to be completed in Q1 fiscal 2025. - The global electrophysiology devices market valued at $6.1 billion in 2022, expected to grow. Price Impact Rating: Bullish Impact Horizon Rating: Long-term Type: Corporate Developments
- Haemonetics acquires Attune Medical for $160 million, boosting the global Hospital business.
- Attune Medical generated $22 million in revenue in fiscal 2023, expected accretive to Haemonetics.
- Attune's ensoETM technology enhances Haemonetics' presence in electrophysiology market.
- Transaction financed through cash and credit facility draw, expected to be completed in Q1 fiscal 2025.
- The global electrophysiology devices market valued at $6.1 billion in 2022, expected to grow.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.